Anticoagulation is mainstay therapy for patients with acute pulmonary embolism while
systemic thrombolysis is reserved for those with hemodynamic instability. Over the last …

Abstract Introduction The EXTRACT‐PE trial evaluated the safety and performance of the
Indigo Aspiration System (Penumbra Inc.) with an 8F continuous mechanical aspiration …

Objective Review the most commonly used percutaneous mechanical thrombectomy
devices for the treatment of pulmonary embolism today. Methods A thorough search of the …

Objectives This study sought to prospectively evaluate the safety and efficacy of the Indigo
aspiration system in submassive acute pulmonary embolism (PE). Background PE treatment …

Studies have demonstrated that right ventricular (RV) dysfunction is a key factor in negative
clinical outcomes following acute pulmonary embolism (PE)(1). Advanced therapies …

Purpose To evaluate the feasibility of aspiration thrombectomy in patients with acute
massive or submassive pulmonary embolism (PE). Materials and Methods This prospective …

Introduction This study describes the experience of a reference center using continuous
aspiration mechanical thrombectomy for acute high-and intermediate-high-risk pulmonary …

Objectives. We sought to assess the technical and clinical feasibility of continuous aspiration
catheter‐directed mechanical thrombectomy (CDT) in patients with high‐or intermediate …

Background: Mechanical thrombectomy plays an important role in the management of acute
pulmonary embolism (PE), either when rapid clot dissolution is needed or when …

Purpose To report initial experience with safety and efficacy in the treatment of pulmonary
embolism (PE) using the FlowTriever device. Materials and Methods A single-center …